Nasal sprays reduce cold duration in at-risk patients by 25%: Study
HQ Team July 18, 2024: A United Kingdom study found that Over-the-counter (OTC) nasal sprays can reduce the symptoms and duration of respiratory.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team July 18, 2024: A United Kingdom study found that Over-the-counter (OTC) nasal sprays can reduce the symptoms and duration of respiratory.
HQ Team July 18, 2024: Researchers at the Virginia Commonwealth University’s School of Medicine and the Richmond VA Medical Center say that almost.
Conduct disorder is a result of extensive changes in the structure of the brain and is most noticeable in the cerebral cortex, or.
HQ Team July 18, 2024: In a reversal strategy in the war against cancer, researchers are now aiming to genetically cloak healthy cells.
Japanese researchers have developed a non-invasive alternative to detect human papillomavirus by testing urine samples, a discovery that may transform cervical cancer screening.
British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.
Climate change is making days longer by a few milliseconds as the ice melts in Antarctica and Greenland is causing a shift in.
HQ Team July 16, 2024: A new animal study has found a new therapy that is able to boost inuslin-producing cells by 700%.
HQ Team July 16, 2024: A new study by Northwestern Medicine and Brigham and Women’s Hospital researchers has identified a possible cause for.
Novo Nordisk, has been denied approval for its type 1 diabetic medicine by the USFDA, according to the Danish drugmaker.